TransMedics Group, Inc.
NASDAQ: TMDX. Canonical company identity and public leadership record.
US
- Alpha ID
- alpha:company:36ea34e7-2b53-432d-ae5b-ad279ba3049f
- SEC CIK
- 0001756262
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 20, 2026
- Newest evidence
- Apr 10, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Waleed H. HassaneinSince Feb 24, 2026
- Chair
- James R. Tobin
- Independent
- Not published8 directors published
- Published claims
- 223 distinct sources
- Evidence records
- 50 pinned
- Source conflicts
- 0None open
Built from 3 distinct sources and 5 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
DIRECTOR APPOINTED
Giovanni Cecere seat on TransMedics Group, Inc., effective 2026-04-10.
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Chief Financial Officer | Gerardo P. Hernandez Omana | Feb 2026 | current | Source reportedE4 |
| President, Chief Executive Officer and member of the Board of Directors | Waleed H. Hassanein | Feb 2026 | current | Source reportedE5 |
| Chief Financial Officer and Treasurer | Gerardo Hernandez | Not captured | unknown | Source reportedE2 |
| Chief Commercial Officer | Giovanni Cecere | Not captured | unknown | Source reportedE2 |
| Senior Vice President, General Counsel and Corporate Secretary | Matthew Forsyth | Not captured | unknown | Source reportedE2 |
| Senior Vice President of Supply Chain and Operations | Nicholas Corcoran | Not captured | unknown | Source reportedE2 |
| President and Chief Executive Officer | Waleed H. Hassanein, M.D. | Not captured | unknown | Source reportedE2 |
Board of directors
Evidence8 directors published. Independence determinations are not published for every director.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| David Weill | Independence not published | 2019 | None published | Source reportedE3 |
| Edward M. Basile | Independence not published | 2016 | None published | Source reportedE3 |
| Edwin M. Kania, Jr | Independence not published | 2003 | None published | Source reportedE3 |
| Giovanni Cecere | Independence not published | 2026 | None published | Source reportedE3 |
| Merilee Raines | Independence not published | 2021 | None published | Source reportedE3 |
| Stephanie Lovell | Independence not published | 2021 | None published | Source reportedE3 |
| Thomas J. Gunderson | Independence not published | 2016 | None published | Source reportedE3 |
| Waleed H. Hassanein | Independence not published | 1998 | None published | Source reportedE3 |
| David Weill, M.D. | Independent | Not published | None published | Source reportedE2 |
| James R. Tobin | IndependentChair | Not published | None published | Source reportedE2 |
| Waleed H. Hassanein, M.D. | Not independent | Not published | Chief Executive Officer and Director | Source reportedE2 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Chief Executive Officer and Director | Not published | Waleed H. Hassanein, M.D. | Not described in the published record |
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Financials and market context
EvidenceGovernance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Gerardo P. Hernandez OmanaChief Financial Officercompany:36ea34e7-2b53-432d-ae5b-ad279ba3049f:leadership_role:17
- Waleed H. HassaneinPresident, Chief Executive Officer and member of the Board of Directorscompany:36ea34e7-2b53-432d-ae5b-ad279ba3049f:leadership_role:21, company:36ea34e7-2b53-432d-ae5b-ad279ba3049f:leadership_role:14
- Gerardo HernandezChief Financial Officer and Treasurercompany:36ea34e7-2b53-432d-ae5b-ad279ba3049f:leadership_role:16
- Giovanni CecereChief Commercial Officer; Directorcompany:36ea34e7-2b53-432d-ae5b-ad279ba3049f:leadership_role:18, company:36ea34e7-2b53-432d-ae5b-ad279ba3049f:leadership_role:10
- Matthew ForsythSenior Vice President, General Counsel and Corporate Secretarycompany:36ea34e7-2b53-432d-ae5b-ad279ba3049f:leadership_role:19
- Nicholas CorcoranSenior Vice President of Supply Chain and Operationscompany:36ea34e7-2b53-432d-ae5b-ad279ba3049f:leadership_role:20
- Waleed H. Hassanein, M.D.President and Chief Executive Officer; President, Chief Executive Officer and Directorcompany:36ea34e7-2b53-432d-ae5b-ad279ba3049f:leadership_role:22, company:36ea34e7-2b53-432d-ae5b-ad279ba3049f:leadership_role:15
- David WeillDirectorcompany:36ea34e7-2b53-432d-ae5b-ad279ba3049f:leadership_role:6
- Edward M. BasileDirectorcompany:36ea34e7-2b53-432d-ae5b-ad279ba3049f:leadership_role:8
- Edwin M. Kania, JrDirectorcompany:36ea34e7-2b53-432d-ae5b-ad279ba3049f:leadership_role:9
- Merilee RainesDirectorcompany:36ea34e7-2b53-432d-ae5b-ad279ba3049f:leadership_role:11
- Stephanie LovellDirectorcompany:36ea34e7-2b53-432d-ae5b-ad279ba3049f:leadership_role:12
- Thomas J. GundersonDirectorcompany:36ea34e7-2b53-432d-ae5b-ad279ba3049f:leadership_role:13
- David Weill, M.D.Directorcompany:36ea34e7-2b53-432d-ae5b-ad279ba3049f:leadership_role:7
- James R. TobinChairperson of the Boardcompany:36ea34e7-2b53-432d-ae5b-ad279ba3049f:leadership_role:5
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 5 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 20, 2026. Cited by 4 Claims.
- E2sec def 14a. Published Apr 10, 2026. Retrieved Sep 13, 2026. Cited by 8 Claims.
- E3sec proxy. Published Apr 10, 2026. Retrieved Sep 2, 2026. Cited by 8 Claims.
- E4sec filing. Published Feb 24, 2026. Retrieved May 5, 2026. Cited by 1 Claim.
- E5sec filing. Published Feb 24, 2026. Retrieved May 5, 2026. Cited by 1 Claim.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 20, 2026- Giovanni Cecere seat on TransMedics Group, Inc., effective 2026-04-10.
- Gerardo P. Hernandez Omana executive of TransMedics Group, Inc., effective 2026-02-24.
- Waleed H. Hassanein executive of TransMedics Group, Inc., effective 2026-02-24.
- Merilee Raines seat on TransMedics Group, Inc., effective 2021-01-01.
- Stephanie Lovell seat on TransMedics Group, Inc., effective 2021-01-01.
- David Weill seat on TransMedics Group, Inc., effective 2019-01-01.
- Edward M. Basile seat on TransMedics Group, Inc., effective 2016-01-01.
- Thomas J. Gunderson seat on TransMedics Group, Inc., effective 2016-01-01.
- Edwin M. Kania, Jr seat on TransMedics Group, Inc., effective 2003-01-01.
- Waleed H. Hassanein seat on TransMedics Group, Inc., effective 1998-01-01.

